FDA Approves First Drug to Delay Onset of Type 1 Diabetes Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all Nov 18, 2022
Mixed Results With Pemafibrate in Patients With Type 2 Diabetes No impact on CV events in PROMINENT; developer brings trial to an end Nov 06, 2022
Psilocybin for Depression; What's the Best Direct Oral Anticoagulant? Also in TTHealthWatch: hormone therapy to prevent chronic disease Nov 05, 2022 podcast
Empagliflozin Protects At-Risk Patients From CKD Progression Also cut risk for cardiovascular-related death and worsening kidney function Nov 04, 2022
Low-Carb Diet Helps Cut HbA1c in Prediabetes Could be a useful approach for preventing, treating type 2 diabetes, says researcher Oct 26, 2022
Insulin Rationing Common Among Patients With Diabetes More than a million Americans may be engaging in the risky practice, researchers said Oct 17, 2022
SGLT2 Inhibitors, GLP-1 RAs Not Cost-Effective as First-Line T2D Agents Cost-effectiveness study compared lifetime costs with first-line metformin Oct 03, 2022
Incidence of Dry Eye Disease Lower With SGLT2 Inhibitors Retrospective study in Taiwan reported 22% risk reduction compared with GLP-1 receptor agonists Sep 24, 2022
Women With Type 2 Diabetes Die Sooner Than Men, Study Suggests Other groups at risk for early mortality include smokers, those diagnosed at younger ages Sep 23, 2022
Hysterectomy: Another Diabetes Risk Factor? Preservation of ovaries played into this association Sep 22, 2022
Eye Damage Can Start in Prediabetes Study found significant corneal nerve damage even before full-blown type 2 diabetes Sep 22, 2022
Our Hands Are Tied: Treating Prediabetes in Kids We urgently need more research on pharmacological interventions for this growing epidemic Sep 14, 2022
Do Some ľ¹ÏÖ±²¥ Need to Get Better at Documenting Hypertension in Patient Notes? Study finds settings where BP documentation is especially lax Sep 11, 2022
Artificial Pancreas Improves Glycemic Control After Total Pancreatectomy Dutch trial showed more time spent with normal glucose levels versus usual care Sep 08, 2022
Prescribing of Newer Diabetes Drugs Not Up to Snuff in Black Patients? Study among veterans suggests disparities in prescription rates for these type 2 diabetes drugs Sep 06, 2022
How Have Glucagon Costs Changed in Recent Years? Wholesale costs spiked from 2010 to 2020, but out-of-pocket prices remained mostly stable Aug 30, 2022
Mass Cardiovascular Testing May Add Years for Some Men Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
Combining Common Diabetic Nerve Pain Drugs Helped Provide More Relief No specific combination stood out among the crowd Aug 24, 2022
Can Lower Gestational Diabetes Cutoff Improve Outcomes in Kids? About 9% of babies born large for gestational age regardless of the approach to diagnosis Aug 17, 2022
CDC: More Clots, Kidney Failure in Kids After COVID Post-COVID symptoms run the gamut for kids and teens Aug 05, 2022
Minimally Invasive Bariatric Procedure Effective for Milder Obesity Big weight loss seen in patients with mild and moderate levels of obesity Aug 02, 2022
Dear Insurers: It's Time to Cover Weight Loss Drugs Universal coverage can increase medication access and improve population health Jul 27, 2022
Keto Versus Mediterranean Diet: Which Is Better for Diabetes? Crossover study looked at cardiometabolic outcomes for each popular diet Jul 08, 2022
Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
Primary Care Screening Flops in Detecting Diabetic Eye Disease Fundoscopy screening had low sensitivity, accuracy in primary care setting Jun 28, 2022
Prediabetes May Be an Independent Risk Factor for MI Findings reinforce importance of early screening and intervention, researchers says Jun 12, 2022
ADA 2022: Racial Residential Segregation, DKA During COVID, and More Noteworthy research presented at the American Diabetes Association annual meeting Jun 08, 2022
Concerning Trends in Vision Impairment for Adults With Diabetes? Steady decreases in the prevalence of patients with eye problems may be over Jun 07, 2022
Tirzepatide Reduced Albuminuria in T2D Patients With Heart Risk Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
Is Diabetes a Risk Factor for Long COVID? Possibly. Mixed results in seven-study scoping review Jun 05, 2022
Dulaglutide Improves HbA1c for Youth With Type 2 Diabetes Safety profile consistent with that reported in adults Jun 05, 2022
Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesity SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
No Cardioprotection Seen With Long-Term Metformin or Lifestyle Intervention Both approaches "highly effective" in T2D, but not for preventing CV disease, expert says May 24, 2022
Diabetic Pain Relief Lasts With High Frequency Spinal Cord Stimulation Trial followed patients with Senza System for 18 months May 16, 2022
Patients With Type 2 Diabetes and CKD Face Poor COVID Outcomes Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more May 15, 2022
First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease? Study finds estimated annual progression rate to diabetes of 5.3% Apr 20, 2022
Who Is Really Driving Up Insulin Costs? More attention needs to focus on pharmaceutical middlemen Apr 18, 2022
In Type 2 Diabetes, Metabolic Control Could Add Years to Life Controlling four biomarkers could add as much as a decade to life expectancy Apr 18, 2022
The Winners and Losers of the Proposed Insulin Cost Cap While it benefits some, the $35 cap is only a stopgap measure Apr 08, 2022
